Medtronic plc, has received approval from the US FDA for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads. Background … continue reading “Two New FDA-Approved Bladder and Bowel Control Therapies”
Approval/Clearance
CMS Approval for SINUVA® Sinus Implant
Intersect ENT®, Inc., a company dedicated to transforming care for patients with ear, nose and throat conditions, has gained Centers … continue reading “CMS Approval for SINUVA® Sinus Implant”
CE Mark for Ortho’s COVID-19 IgG Antibody Test
A few weeks ago we reported that Ortho Clinical Diagnostics had seen its COVID-19 total antibody test CE marked. Now … continue reading “CE Mark for Ortho’s COVID-19 IgG Antibody Test”
Now Ortho’s COVID Antibody Test Gains CE Mark
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics has announced that its COVID-19 total antibody test received CE … continue reading “Now Ortho’s COVID Antibody Test Gains CE Mark”
FDA Emergency Use Authorization for Ortho’s COVID-19 Total Antibody Test
The U.S. FDA has granted Emergency Use Authorization to Ortho Clinical Diagnostics’ total antibody assay for COVID-19 – the VITROS® … continue reading “FDA Emergency Use Authorization for Ortho’s COVID-19 Total Antibody Test”
CE Mark for “World First” Single-Use Duodenoscope, EXALT Model D
Boston Scientific Corporation has gained the CE Mark and initiated a limited market release of the EXALT™ Model D Single-Use (disposable) … continue reading “CE Mark for “World First” Single-Use Duodenoscope, EXALT Model D”
Newly Cleared Cranial Robotic System Sees First Paediatric Deployment
Phoenix Children’s Hospital, is the first health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth … continue reading “Newly Cleared Cranial Robotic System Sees First Paediatric Deployment”
XACT Robotic System Cleared by FDA for Percutaneous Interventional Procedures
XACT Robotics™ Ltd. tells us that its first robotic system has been cleared to market in the U.S. for use during … continue reading “XACT Robotic System Cleared by FDA for Percutaneous Interventional Procedures”
CE Mark for Boston Scientific’s VERCISE™ Neural Navigator 3 Programming Software
Boston Scientific Corporation has announced the CE Mark approval of its Vercise™ Neural Navigator 3 directional Deep Brain Stimulation (DBS) programming … continue reading “CE Mark for Boston Scientific’s VERCISE™ Neural Navigator 3 Programming Software”
FDA Breakthrough Device Designation for SoniVie’s TIVUS Pulmonary Arterial Hypertension System
Pulmonary Arterial Hypertension (PAH) treatment specialist SoniVie, has been granted Breakthrough Device Designation from the U.S. FDA for the Therapeutic … continue reading “FDA Breakthrough Device Designation for SoniVie’s TIVUS Pulmonary Arterial Hypertension System”
CE Mark for Orchestra BioMed BackBeat Cardiac Neuromodulation Therapy™ for Hypertension
Orchestra BioMed™, Inc., tells us it has received CE Mark approval for its Moderato® implantable pulse generator system that delivers BackBeat … continue reading “CE Mark for Orchestra BioMed BackBeat Cardiac Neuromodulation Therapy™ for Hypertension”
U.S. Approval for Next-Generation MitraClip®
Abbott tells us it has received U.S. FDA approval for the fourth generation of of its MitraClip™ heart valve repair device to treat … continue reading “U.S. Approval for Next-Generation MitraClip®”
FDA Clearance for eon™ FR, Non-Contact Body Sculpting
Dominion Aesthetic Technologies, Inc. has received U.S FDA clearance for its body contouring product, eon™ FR, a non-contact medical device that that … continue reading “FDA Clearance for eon™ FR, Non-Contact Body Sculpting”
FDA Clearance of Steerable Introducer for Transseptal Access/Delivery
BioCardia shows its newly cleared transseptal access system at Heart Rhythm Society congress in San Francisco
COPD: FDA Breakthrough Device Designation for CSA Medical RejuvenAir® System
The RejuvenAir® System has been designated as a Breakthrough Device by the U.S. FDA. The company has also received unconditional IDE approval to initiate a pivotal clinical study.
U.S. FDA Clearance for Retia Medical’s Argos Cardiac Output Patient Monitor
The link between hemodynamic monitoring and improved clinical outcome is well established. Retia Medical says its newly cleared Argos cardiac output monitor brings with it a new level of accuracy